NSAIDs after injury: helpful or harmful?

Non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, diclofenac, and others) work primarily by inhibiting cyclooxygenase (COX) enzymes. These enzymes produce prostaglandins, signalling molecules that drive the redness, swelling, heat, and pain of the inflammatory response. Block COX, and prostaglandin levels fall, which is why NSAIDs reduce swelling and pain so reliably.

The complication is that prostaglandins are not purely destructive. They also act as early signals in the tissue-repair cascade, helping recruit the cells that clear debris and begin laying down new collagen and bone matrix. Suppressing them can therefore have a double-edged effect: less pain and swelling in the short run, potentially slower or lower-quality tissue repair over the following weeks.

That trade-off plays out differently depending on the tissue involved: bone, tendon, and muscle each rely on the inflammatory cascade to different degrees and in different ways.

The strongest argument for short-term NSAID use after injury is functional. Acute musculoskeletal pain that prevents sleep, weight-bearing, or normal movement is not neutral; immobility has its own costs for recovery, and inadequate pain control can interfere with early rehabilitation. In that context, a brief course of an NSAID at a standard over-the-counter dose can be a sensible choice.

NSAIDs are also well-suited to situations where the primary goal is controlling an exaggerated inflammatory response rather than tissue repair. Bursitis, inflammatory tendinopathy flares, and conditions where swelling itself is the problem may respond well and without the same healing trade-offs seen in acute fractures or surgical repairs.

The key distinction is between using an NSAID to manage acute pain for a day or two so you can function, versus using it continuously for a week or more to keep inflammation suppressed throughout the critical healing window.

The case against routine NSAID use during injury recovery comes from several tissue types, and the evidence is strongest for bone.

A review published in Current Opinion in Rheumatology examined the clinical and experimental evidence on NSAIDs and fracture healing.^[2] The authors found consistent signals (across animal studies and human observational data) that NSAIDs, particularly with longer or higher-dose use, may delay fracture union and reduce the mechanical strength of the healed bone. The effect appeared most pronounced in the early phases of repair, when the inflammatory response is laying the groundwork for new bone formation.

For tendons, a systematic review and meta-analysis looked at the effect of NSAIDs on tendon-to-bone healing, the type of repair required after rotator cuff surgery or ACL reconstruction.^[3] Animal model data showed consistent impairment of early tendon-to-bone integration. Human data were more limited but directionally consistent, raising concern about routine NSAID use in the post-surgical or acute repair context.

Muscle adaptation adds a third dimension. A randomised trial in young adults found that high-dose ibuprofen (1200 mg/day) over 8 weeks of resistance training significantly reduced gains in muscle strength and hypertrophy compared with low-dose aspirin.^[1] The mechanism is thought to involve prostaglandins' role in satellite cell activation and muscle protein synthesis; again, the same signalling pathway that drives discomfort also drives adaptation.

Across the available evidence, two variables consistently modify the risk of impaired healing: how long NSAIDs are used, and at what dose.

The early inflammatory phase (roughly the first 3–7 days after injury or surgery) appears to be the window where prostaglandin signalling is most important to downstream repair quality. Animal studies that administer NSAIDs only in this window tend to show the most pronounced effects on bone and tendon healing outcomes. Human observational data on fracture healing similarly point to duration of use as a key factor.

Dose matters separately from duration. The high-dose effects on muscle adaptation (and the animal fracture and tendon data) generally used doses above standard over-the-counter recommendations. A single, low-dose ibuprofen tablet taken once for acute pain is mechanistically different from sustained dosing at the ceiling of the recommended range.

COX-2 selective inhibitors (e.g. celecoxib) are sometimes discussed as having a different profile; COX-2 is more inflammatory, and selective inhibition spares COX-1, which is involved in protective gut prostaglandins. However, COX-2 also plays a role in bone and tendon repair, and the healing concerns are not clearly resolved by switching to a selective inhibitor.

Given the evidence, a reasonable framework for most people looks like this:

Acute pain management: If pain is severe enough to prevent sleep or weight-bearing, a short course (1–2 days) at the lowest effective dose is a defensible choice. Paracetamol (acetaminophen) is a reasonable alternative for pain without the anti-inflammatory mechanism, and avoids the tissue-repair trade-offs entirely.

Bone injuries: If a fracture is suspected or confirmed, the evidence for NSAID caution is strongest here. Discuss with a clinician before using NSAIDs for anything beyond brief symptomatic relief in the acute phase.

Post-surgical tendon repair: Rotator cuff repairs, ACL reconstructions, and similar procedures involve tendon-to-bone healing that may be impaired by NSAIDs. Post-operative pain protocols typically have specific guidance; follow the treating surgeon's advice rather than defaulting to over-the-counter NSAIDs.

Training and adaptation: If your goal is muscle strength and hypertrophy, habitual high-dose NSAID use during training blocks is worth reconsidering in light of the evidence on blunted adaptation.

NSAIDs are effective analgesics, and the case for short-term, low-dose use to manage acute pain after injury is reasonable. The evidence for harm concentrates on a specific pattern: higher doses, sustained over days to weeks, during the critical early repair window, particularly for bone fractures and tendon-to-bone healing.

The practical implication is to use NSAIDs deliberately rather than avoiding them categorically. For most musculoskeletal injuries, the lowest effective dose for the shortest time needed is the right target. If bone healing or tendon repair is central to your recovery, the trade-off tilts more clearly toward caution.